LYTENAVA™ is the first and only approved ophthalmic formulation of bevacizumab for the treatment of wet AMD in the European Union (EU) and United Kingdom (UK)2.8 million injections of repackaged ...

Toronto Ultra, a CDL franchise owned by OverActive Media, has announced it has extended its existing partnership with ...

LYTENAVATM is the first and only approved ophthalmic formulation of bevacizumab for the treatment of wet AMD in the European Un ...

Outlook Therapeutics commenced commercial launch of LYTENAVA™ (bevacizumab gamma) in Germany and the UK as a treatment for wet AMD. In the United States, ONS-5010/LYTENAVA™ is ...

AMD's margins are quickly ticking up, and Wall Street is anticipating this. As a result, they expect strong earnings growth ...

AMD held a Computex press event to introduce its Radeon RX 9060 XT graphics cards and Threadripper CPUs for next-gen gaming and workstations.

A massive insider purchase just hit Advanced Micro Devices (AMD), and it’s raising eyebrows across Wall Street. Philip Guido, ...

These include, among others, the success of Outlook Therapeutics' commercial launch of LYTENAVA™ in Germany ... the therapeutic potential of LYTENAVA™ as a treatment of wet AMD, expectations ...

A top executive at Advanced Micro Devices Inc. (NASDAQ: AMD) made a sizable open market purchase in the stock this week, ...

In a landmark event that reaffirms its commitment to advancing Sri Lanka’s digital landscape, Lenovo, the global technology ...

At the same time, commercial PCs are turning out to be another key growth driver for AMD. Its sell-through of commercial PC processors was up by 30% from the year-ago period. That wasn't ...

ASUS and AMD today jointly announced the launch of the all-new ASUS Expert P-series Copilot+ PCs at Computex 2025, ...